In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
|Articles|May 20, 2020
Examining the prevalence of prediabetes in pediatrics (VIDEO)
Author(s)Bobby Lazzara, MD
For Contemporary Pediatrics, Dr Bobby Lazarra discusses a survey study published in JAMA Pediatrics that looks at the prevalence of prediabetes in the pediatric population of the United States.
Advertisement
For Contemporary Pediatrics, Dr Bobby Lazarra discusses a survey study published in JAMA Pediatrics that looks at the prevalence of prediabetes in the pediatric population of the United States.
Advertisement
Related to this article
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
Nationwide Children's experts urge early screening and family-based lifestyle change as youth-onset T2D progresses faster than adult disease.
Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.
Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.
Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recognizing skin conditions in children with darker skin tones
2
FAQ: How should pediatricians manage UTIs under new AAP guidance?
3
Global measles cases in children under 5 up 40% since COVID-19
4
Tezepelumab sustains EoE remission through 52 weeks
5